We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Improved Optics and Software to Augment a Live-Cell Imaging System

By LabMedica International staff writers
Posted on 25 Jan 2011
Enhanced hardware and software features have been added to a top-of-the-line live-cell imaging system, which will create new standards for data management.

The Thermo Scientific (Milford, MA, USA) ArrayScan VTI HCS Reader is a modular high content screening (HCS) instrument designed for high-capacity automated fluorescence imaging and quantitative analysis of fixed and live cells. More...
The instrument was designed to provide a platform for researchers to study cellular function in fixed or live cells. High content imaging allows the measurement of events in, on, and around cells over time and has significantly improved drug discovery and systems biology through deeper insights into the understanding of cell functions.

Now, Thermo Fisher has released several new hardware and software enhancements to its flagship Arrayscan VTI HCS Reader. These enhancements are part of the Thermo Scientific High-Content 2.0 program and include the integration of Zeiss (Jena, Germany) Definite Focus hardware into the Arrayscan VTI HCS Reader's live cell configuration. This change is designed to better support high-content analysis of living cells, such as the study of calcium signaling, pharmacokinetics, and toxicity.

This new hardware configuration coupled with Thermo Scientific's existing wide range of kinetic measurement tools, offers researchers increased flexibility and the ability to investigate myriad cellular processes in live cells.

Related Links:
Thermo Scientific
Zeiss


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Chromogenic Culture System
InTray™ COLOREX™ ECC
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.